| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |